novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
Published 7 years ago • 3.1K plays • Length 31:21Download video MP4
Download video MP3
Similar videos
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
40:27
integrating novel developments for advanced and metastatic breast cancer into improved care pathways
-
31:56
novel therapeutics for breast cancer: cdk inhibitors, immunotherapy, and role of tils
-
44:23
metastatic breast cancer: leveraging clinical pathways to navigate a complex treatment landscape:
-
46:00
advanced breast cancer: challenges in pathways development
-
5:20
novel approaches for her2-negative metastatic breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
4:29
novel therapeutic targets for breast cancer
-
28:03
triple negative breast cancer - o'regan
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
0:35
triple negative or her 2 positive breast cancer - penn state health
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
9:02
novel therapies in the management of her2-positive breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
0:53
enhancing triple negative breast cancer treatment with immunotherapy across all settings